Darifenacin 33342-0276
Product NDC
33342-0276- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 29, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA207302
Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Darifenacin Hydrobromide | 7.5 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Packaging Options(3)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-07)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-10)
10 BLISTER PACK in 1 CARTON (33342-276-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK